Oculis Announces Public Listing After Completing Business Combination Between European Biotech Acquisition Corp. And Oculis SA
CFGI’s Capital Markets team assisted Oculis Holding AG (“Oculis”) with its listing on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp.